Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control
1 other identifier
observational
176
0 countries
N/A
Brief Summary
Study is an observational study among hypertensive patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2014
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2014
CompletedFirst Submitted
Initial submission to the registry
August 24, 2017
CompletedFirst Posted
Study publicly available on registry
August 24, 2022
CompletedAugust 24, 2022
August 1, 2022
6 months
August 24, 2017
August 23, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
health related quality of life.
EQ-5D-3L turkish validation test
at the time of the beginning of the study
Age
years
at the time of the beginning of the study
Gender
Female/Male
at the time of the beginning of the study
BMI
(kg/m2)
at the time of the beginning of the study
Secondary Outcomes (1)
complementary and alternative medicine use
at the time of the beginning of the study
Study Arms (2)
controlled hypertension
Controlled hypertension was defined as systolic blood pressure (SBP) ≤139 mmHg and/or diastolic blood pressure (DBP)≤89 mmHg for non-diabetic patients, and as SBP ≤139 mmHg and/or DBP ≤84 mmHg for diabetic patients, based on the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) guidelines. observational study
uncontrolled hypertensive patients.
Individuals who had blood pressure levels above these values were defined as uncontrolled hypertensive patients.
Eligibility Criteria
hypertensive patients
You may qualify if:
- aged between 38 and 74 years,
- hypertension diagnosis history of at least 6 months
- use of at least one antihypertensive medication.
You may not qualify if:
- not willing to join the clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maltepe Universitylead
- Istanbul Universitycollaborator
Related Publications (2)
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc. No abstract available.
PMID: 23817082BACKGROUNDÖzünal, Z. G., Tahirbegolli, I. A., Baykal, M., Belen, A. T. E. Ş., Tahirbegolli, B., KILIÇ, Y., ... & Üresin, A. Y. (2019). The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof
Study Record Dates
First Submitted
August 24, 2017
First Posted
August 24, 2022
Study Start
June 16, 2014
Primary Completion
November 30, 2014
Study Completion
November 30, 2014
Last Updated
August 24, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share